| Ipca Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524494 |
NSE Symbol : IPCALAB |
P/E(TTM) : 38.22 |
|
ISIN Demat : INE571A01038 |
Div & Yield% : 0.27 |
EPS(TTM) : 38.18 |
|
Book Value(₹) : 291.98 |
Market Cap(₹Cr) : 37,023.06 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,930.32 | 1,746.90 | 1,638.44 | 1,662.68 | 1,810.94 | 1,565.86 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,930.32 | 1,746.90 | 1,638.44 | 1,662.68 | 1,810.94 | 1,565.86 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 21.92 | 25.02 | 21.49 | 17.41 | 17.00 | 15.39 |
| Total Income | 1,952.24 | 1,771.92 | 1,659.93 | 1,680.09 | 1,827.94 | 1,581.25 |
| Total Expenditure | 1,465.61 | 1,339.98 | 1,561.39 | 1,251.59 | 1,408.83 | 1,212.62 |
| PBIDT | 486.63 | 431.94 | 98.54 | 428.50 | 419.11 | 368.63 |
| Interest | 11.46 | 12.06 | 16.20 | 10.17 | 17.25 | 19.42 |
| PBDT | 475.17 | 419.88 | 82.34 | 418.33 | 401.86 | 349.21 |
| Depreciation | 66.86 | 63.13 | 65.19 | 62.81 | 62.65 | 61.32 |
| Tax | 104.52 | 92.66 | 75.90 | 89.50 | 94.50 | 81.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.95 | 2.05 | 6.30 | -1.54 | 0.59 | 2.76 |
| Reported Profit After Tax | 304.74 | 262.04 | -65.05 | 267.56 | 244.12 | 204.13 |
| Extra-ordinary Items | 0.00 | 0.00 | -199.34 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 304.74 | 262.04 | 134.29 | 267.56 | 244.12 | 204.13 |
| EPS (Unit Curr.) | 12.01 | 10.33 | -2.56 | 10.55 | 9.62 | 8.05 |
| EPS (Adj) (Unit Curr.) | 12.01 | 10.33 | -2.56 | 10.55 | 9.62 | 8.05 |
| Calculated EPS (Unit Curr.) | 12.01 | 10.33 | -2.56 | 10.55 | 9.62 | 8.05 |
| Calculated EPS (Adj) (Unit Curr.) | 12.01 | 10.33 | -2.56 | 10.55 | 9.62 | 8.05 |
| Calculated EPS (Ann.) (Unit Curr.) | 48.05 | 41.31 | -10.26 | 42.19 | 38.49 | 32.18 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 48.05 | 41.31 | -10.26 | 42.19 | 38.49 | 32.18 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 200.00 | 0.00 |
| Equity | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 25.21 | 24.73 | 6.01 | 25.77 | 23.14 | 23.54 |
| PBDTM(%) | 24.62 | 24.04 | 5.03 | 25.16 | 22.19 | 22.30 |
| PATM(%) | 15.79 | 15.00 | -3.97 | 16.09 | 13.48 | 13.04 |